Avanos Medical, Inc. (AVNS)
Price:
13.64 USD
( - -1.59 USD)
Your position:
0 USD
ACTION PANEL
ABOUT
Check the
KEY TAKEAWAYS
ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
(REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION
SIMILAR COMPANIES STI SCORE
Similar STI Score
Abbott Laboratories
VALUE SCORE:
6
2nd position
Stryker Corporation
VALUE SCORE:
9
The best
Inspire Medical Systems, Inc.
VALUE SCORE:
11
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS PER SHARE
TECHNICAL
DIVIDEND
SIMILAR COMPANIES
DESCRIPTION
Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions; and respiratory health products, such as closed airway suction systems and other airway management devices under the Ballard, Microcuff, and Endoclear brands. The company also provides a portfolio of non-opioid pain solutions, including acute pain products, such as On-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems; and interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.
NEWS
Avanos Medical, Inc. (AVNS) Q4 2025 Earnings Call Transcript
seekingalpha.com
2026-02-24 12:27:59Avanos Medical, Inc. (AVNS) Q4 2025 Earnings Call Transcript
Avanos Medical (AVNS) Q4 Earnings and Revenues Surpass Estimates
zacks.com
2026-02-24 10:41:41Avanos Medical (AVNS) came out with quarterly earnings of $0.29 per share, beating the Zacks Consensus Estimate of $0.24 per share. This compares to earnings of $0.43 per share a year ago.
Avanos Medical, Inc. Announces Fourth Quarter and Full-Year 2025 Results
prnewswire.com
2026-02-24 07:00:00Exceeded full-year revenue and achieved the top end of full-year earnings-per-share guidance Delivered full-year organic growth of 6% in strategic segments Expanded transformation initiatives expected to deliver $15 to $20 million of incremental annualized savings by the end of 2026 ALPHARETTA, Ga., Feb. 24, 2026 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported fourth quarter and full-year 2025 results.
Avanos Medical, Inc. to Webcast Conference Call Discussing Fourth Quarter and Full Year 2025 Financial Results
prnewswire.com
2026-02-16 16:30:00ALPHARETTA, Ga., Feb. 16, 2026 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the fourth quarter and full year 2025 on Tues.
CMS Maintains NOPAIN Act Eligibility for ON‑Q* and AmbIT* Infusion Pumps; Adds Game Ready* in 2026
prnewswire.com
2026-02-03 08:00:00ALPHARETTA, Ga., Feb. 3, 2026 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) announced today that the Centers for Medicare and Medicaid Services (CMS) has released the 2026 Medicare Hospital Outpatient Prospective Payment System (OPPS) and Medicare Ambulatory Surgical Center (ASC) Payment System Final Rule.
Reasons to Retain Avanos Medical Stock in Your Portfolio Now
zacks.com
2026-01-29 14:36:05AVNS shows solid 3Q25 momentum from SNS and PMR growth, aided by M&A and cost cuts, even as tariffs and FX volatility linger.
AVNS & Siemens Healthineers Team Up on Advanced Integrated Pain Care
zacks.com
2026-01-26 11:20:15Avanos Medical teams up with an imaging partner to pair RFA with mobile imaging, targeting the shift of complex pain procedures to outpatient care.
Avanos Medical and Siemens Healthineers Collaborate to Advance Integrated Solutions for Outpatient and Interventional Pain Management
prnewswire.com
2026-01-20 08:00:00ALPHARETTA, Ga., Jan. 20, 2026 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) and Siemens Healthineers today announced a strategic co-marketing agreement to advance outpatient and interventional pain care through an integrated ecosystem of imaging and radiofrequency ablation (RFA) technologies.
Avanos Medical, Inc. (AVNS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
seekingalpha.com
2026-01-13 19:46:00Avanos Medical, Inc. (AVNS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Avanos Medical, Inc. to Present at the 44th Annual J.P. Morgan Healthcare Conference
prnewswire.com
2026-01-07 20:25:00ALPHARETTA, Ga., Jan. 7, 2026 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Dave Pacitti, chief executive officer, will present at the 44th Annual J.P.
New Strong Sell Stocks for January 6th
zacks.com
2026-01-06 06:16:06AVNS, ALG and CLMB have been added to the Zacks Rank #5 (Strong Sell) List on January 6th, 2026.
DexCom (NASDAQ:DXCM) & Avanos Medical (NYSE:AVNS) Head-To-Head Contrast
defenseworld.net
2025-12-30 01:48:53Avanos Medical (NYSE: AVNS - Get Free Report) and DexCom (NASDAQ: DXCM - Get Free Report) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, earnings, dividends and risk. Analyst Recommendations This is a summary of recent ratings
93,572 Shares in Avanos Medical, Inc. $AVNS Bought by Squarepoint Ops LLC
defenseworld.net
2025-12-21 05:14:44Squarepoint Ops LLC purchased a new stake in Avanos Medical, Inc. (NYSE: AVNS) in the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 93,572 shares of the company's stock, valued at approximately $1,145,000. Squarepoint Ops LLC owned 0.20% of
New Strong Sell Stocks for Dec. 17
zacks.com
2025-12-17 07:11:05AVNS, ADM and OZK have been added to the Zacks Rank #5 (Strong Sell) List on Dec. 17, 2025.
Why Is Avanos Medical (AVNS) Down 0.5% Since Last Earnings Report?
zacks.com
2025-12-05 12:36:45Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock?
Envestnet Asset Management Inc. Has $2.57 Million Stock Position in Avanos Medical, Inc. $AVNS
defenseworld.net
2025-11-17 04:34:51Envestnet Asset Management Inc. raised its position in shares of Avanos Medical, Inc. (NYSE: AVNS) by 45.2% in the second quarter, according to its most recent filing with the SEC. The firm owned 210,237 shares of the company's stock after purchasing an additional 65,478 shares during the quarter. Envestnet Asset Management Inc. owned
No data to display
Avanos Medical, Inc. (AVNS) Q4 2025 Earnings Call Transcript
seekingalpha.com
2026-02-24 12:27:59Avanos Medical, Inc. (AVNS) Q4 2025 Earnings Call Transcript
Avanos Medical (AVNS) Q4 Earnings and Revenues Surpass Estimates
zacks.com
2026-02-24 10:41:41Avanos Medical (AVNS) came out with quarterly earnings of $0.29 per share, beating the Zacks Consensus Estimate of $0.24 per share. This compares to earnings of $0.43 per share a year ago.
Avanos Medical, Inc. Announces Fourth Quarter and Full-Year 2025 Results
prnewswire.com
2026-02-24 07:00:00Exceeded full-year revenue and achieved the top end of full-year earnings-per-share guidance Delivered full-year organic growth of 6% in strategic segments Expanded transformation initiatives expected to deliver $15 to $20 million of incremental annualized savings by the end of 2026 ALPHARETTA, Ga., Feb. 24, 2026 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today reported fourth quarter and full-year 2025 results.
Avanos Medical, Inc. to Webcast Conference Call Discussing Fourth Quarter and Full Year 2025 Financial Results
prnewswire.com
2026-02-16 16:30:00ALPHARETTA, Ga., Feb. 16, 2026 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) will webcast its conference call discussing financial results and business highlights for the fourth quarter and full year 2025 on Tues.
CMS Maintains NOPAIN Act Eligibility for ON‑Q* and AmbIT* Infusion Pumps; Adds Game Ready* in 2026
prnewswire.com
2026-02-03 08:00:00ALPHARETTA, Ga., Feb. 3, 2026 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) announced today that the Centers for Medicare and Medicaid Services (CMS) has released the 2026 Medicare Hospital Outpatient Prospective Payment System (OPPS) and Medicare Ambulatory Surgical Center (ASC) Payment System Final Rule.
Reasons to Retain Avanos Medical Stock in Your Portfolio Now
zacks.com
2026-01-29 14:36:05AVNS shows solid 3Q25 momentum from SNS and PMR growth, aided by M&A and cost cuts, even as tariffs and FX volatility linger.
AVNS & Siemens Healthineers Team Up on Advanced Integrated Pain Care
zacks.com
2026-01-26 11:20:15Avanos Medical teams up with an imaging partner to pair RFA with mobile imaging, targeting the shift of complex pain procedures to outpatient care.
Avanos Medical and Siemens Healthineers Collaborate to Advance Integrated Solutions for Outpatient and Interventional Pain Management
prnewswire.com
2026-01-20 08:00:00ALPHARETTA, Ga., Jan. 20, 2026 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) and Siemens Healthineers today announced a strategic co-marketing agreement to advance outpatient and interventional pain care through an integrated ecosystem of imaging and radiofrequency ablation (RFA) technologies.
Avanos Medical, Inc. (AVNS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
seekingalpha.com
2026-01-13 19:46:00Avanos Medical, Inc. (AVNS) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Avanos Medical, Inc. to Present at the 44th Annual J.P. Morgan Healthcare Conference
prnewswire.com
2026-01-07 20:25:00ALPHARETTA, Ga., Jan. 7, 2026 /PRNewswire/ -- Avanos Medical, Inc. (NYSE: AVNS) today announced that Dave Pacitti, chief executive officer, will present at the 44th Annual J.P.
New Strong Sell Stocks for January 6th
zacks.com
2026-01-06 06:16:06AVNS, ALG and CLMB have been added to the Zacks Rank #5 (Strong Sell) List on January 6th, 2026.
DexCom (NASDAQ:DXCM) & Avanos Medical (NYSE:AVNS) Head-To-Head Contrast
defenseworld.net
2025-12-30 01:48:53Avanos Medical (NYSE: AVNS - Get Free Report) and DexCom (NASDAQ: DXCM - Get Free Report) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, earnings, dividends and risk. Analyst Recommendations This is a summary of recent ratings
93,572 Shares in Avanos Medical, Inc. $AVNS Bought by Squarepoint Ops LLC
defenseworld.net
2025-12-21 05:14:44Squarepoint Ops LLC purchased a new stake in Avanos Medical, Inc. (NYSE: AVNS) in the undefined quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 93,572 shares of the company's stock, valued at approximately $1,145,000. Squarepoint Ops LLC owned 0.20% of
New Strong Sell Stocks for Dec. 17
zacks.com
2025-12-17 07:11:05AVNS, ADM and OZK have been added to the Zacks Rank #5 (Strong Sell) List on Dec. 17, 2025.
Why Is Avanos Medical (AVNS) Down 0.5% Since Last Earnings Report?
zacks.com
2025-12-05 12:36:45Avanos Medical (AVNS) reported earnings 30 days ago. What's next for the stock?
Envestnet Asset Management Inc. Has $2.57 Million Stock Position in Avanos Medical, Inc. $AVNS
defenseworld.net
2025-11-17 04:34:51Envestnet Asset Management Inc. raised its position in shares of Avanos Medical, Inc. (NYSE: AVNS) by 45.2% in the second quarter, according to its most recent filing with the SEC. The firm owned 210,237 shares of the company's stock after purchasing an additional 65,478 shares during the quarter. Envestnet Asset Management Inc. owned